ICSL just had a pullback...Tuesday June 29, 8:00 am Eastern Time
Company Press Release
SOURCE: Innovative Clinical Solutions, Ltd.
Innovative Clinical Solutions, Ltd. (ICSL) To Deliver Internet-Based Solutions to Physicians
PROVIDENCE, R.I., June 29 /PRNewswire/ -- Innovative Clinical Solutions, Ltd. (Nasdaq: ICSL - news), formerly PhyMatrix (Nasdaq: PHMX - news), today announced that it has begun to implement its relationship with Cybear, Inc. (Nasdaq: CYBA - news), the Internet-based healthcare communications technology company. ICSL's Network Management division, which manages more than 9,000 physicians through Independent Practice Associations (IPAs) and physician specialty networks, is beginning to install and utilize Cybear's internet-based SolutionsMD(SM) product in the first 1,000 provider offices in ICSL's physician networks. ICSL Clinical Studies and ICSL Healthcare Research also plan to soon begin installation and utilization of Cybear's product throughout their various research locations.
Under their agreement, ICSL and Cybear will explore the joint development of internet-based tools for clinical and outcomes research and disease management programs. These tools will be designed to enable ICSL to implement its strategy of promoting cost-effective healthcare delivery by integrating clinical and outcomes research with medical management, thereby decreasing therapeutic development timelines.
Bryan Dieter, Chief Information Officer at ICSL, said, ''We are pleased to begin the implementation of our relationship with Cybear. Their physician-based product and ability to develop specific applications that are easily implemented and maintained, will allow us to enhance the value of the services we provide to our physician partners. It also presents us with an information tool that we can utilize in implementing many of our growth strategies.''
Innovative Clinical Solutions, Ltd., headquartered in Providence, Rhode Island, provides services that support the needs of the pharmaceutical and managed care industries. The Company integrates its pharmaceutical services division with its provider network management division to create innovative solutions for its customers. The Company's services include clinical and economic research and disease management, as well as managed care functions for specialty and multi-specialty provider networks including more than 9,000 physicians and over 8 million patients nationwide. The Company's components include ICSL Clinical Studies, ICSL Healthcare Research and ICSL Network Management.
This press release contains forward-looking statements regarding future events and the future performance of Innovative Clinical Solutions, Ltd. that involve risks and uncertainties that could cause actual results to differ materially. These risks are described in further detail in the Company's reports filed with the Securities and Exchange Commission.
|
